- Home
- TRVI vs RXST Comparison
TRVI vs RXST Comparison
Compare TRVI & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- RXST
- Stock Information
- Founded
- TRVI 2011
- RXST 1997
- Country
- TRVI United States
- RXST United States
- Employees
- TRVI N/A
- RXST N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- RXST Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TRVI Health Care
- RXST Health Care
- Exchange
- TRVI Nasdaq
- RXST Nasdaq
- Market Cap
- TRVI 629.8M
- RXST 631.1M
- IPO Year
- TRVI 2019
- RXST 2021
- Fundamental
- Price
- TRVI $5.96
- RXST $13.61
- Analyst Decision
- TRVI Strong Buy
- RXST Buy
- Analyst Count
- TRVI 8
- RXST 10
- Target Price
- TRVI $19.31
- RXST $39.30
- AVG Volume (30 Days)
- TRVI 2.5M
- RXST 645.1K
- Earning Date
- TRVI 08-07-2025
- RXST 08-04-2025
- Dividend Yield
- TRVI N/A
- RXST N/A
- EPS Growth
- TRVI N/A
- RXST N/A
- EPS
- TRVI N/A
- RXST N/A
- Revenue
- TRVI N/A
- RXST $148,310,000.00
- Revenue This Year
- TRVI N/A
- RXST $22.16
- Revenue Next Year
- TRVI N/A
- RXST $20.91
- P/E Ratio
- TRVI N/A
- RXST N/A
- Revenue Growth
- TRVI N/A
- RXST 46.70
- 52 Week Low
- TRVI $2.36
- RXST $12.53
- 52 Week High
- TRVI $7.48
- RXST $60.81
- Technical
- Relative Strength Index (RSI)
- TRVI 43.31
- RXST 38.20
- Support Level
- TRVI $6.05
- RXST $13.41
- Resistance Level
- TRVI $6.49
- RXST $14.88
- Average True Range (ATR)
- TRVI 0.53
- RXST 0.73
- MACD
- TRVI -0.05
- RXST -0.14
- Stochastic Oscillator
- TRVI 27.62
- RXST 6.78
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.